Literature DB >> 7718850

Feasibility study of a district tuberculosis control programme with an 8-month short-course chemotherapy regimen utilizing the integrated health service network under field conditions in Nepal.

I Onozaki1, T M Shakya.   

Abstract

SETTING: Tuberculosis in Nepal has not been controlled; there is an annual risk of infection of more than 2%, a cure rate of 30-40% and a casefinding rate of 40%. The necessity of a pilot programme with short-course chemotherapy that could be applied across the nation was discussed, and an operational research project utilizing the existing basic health service network was launched.
OBJECTIVE: The main objective was to assess the feasibility of integrating a tuberculosis programme into the basic health services under various field conditions, and of introducing an 8-month short-course chemotherapy regimen instead of the 12-month standard regimen.
DESIGN: A tuberculosis control programme package based on the current international strategy was introduced in Dhading and Chitawan districts (population 650,000) in 1990. The reported results were confirmed by central supervision and a follow-up study.
RESULTS: 454 new smear-positive cases were found in the first year. 69% were cured and 9% completed their treatment. However an 85% completion rate could be expected from the results of the follow-up study.
CONCLUSION: An integrated tuberculosis control programme with short-course chemotherapy is feasible. An adequate supply of drugs and supervision are vital components. The results showed the possibility of achieving the international target of an 85% cure rate and 70% detection, even within the constraints of the field conditions in Nepal.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7718850     DOI: 10.1016/0962-8479(95)90582-0

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  1 in total

Review 1.  How to assess and prepare health systems in low- and middle-income countries for integration of services-a systematic review.

Authors:  Stephanie M Topp; Seye Abimbola; Rohina Joshi; Joel Negin
Journal:  Health Policy Plan       Date:  2018-03-01       Impact factor: 3.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.